(Q34242912)

English

Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

anticoagulation

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Guido Parodi

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Giuseppe De Luca

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Guia Moschi

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Benedetta Bellandi

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Renato Valenti

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Angela Migliorini

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nazario Carrabba

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

David Antoniucci

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

446-451

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Bivalirudin for patients with acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Protamine--antagonist to heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Protamine: a review of its toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

6 July 2018

Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

28 October 2018

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

28 October 2018

Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

28 October 2018

A preferred reperfusion strategy for acute myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

28 October 2018

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

28 October 2018

Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

28 October 2018

Administration of protamine after coronary stent deployment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964489

28 October 2018

In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20571920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20571920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protamine induces endothelium-dependent vasodilatation of the pulmonary artery

1 reference

https://pubmed.ncbi.nlm.nih.gov/20571920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20571920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement activation from protamine sulfate administration after coronary angiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/20571920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/20571920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20571920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-010-0481-5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34242912&oldid=2196412252"